Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,709 public trials 1,045 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation

NCT02189967

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Universitätsklinikum Dresden, Department of Radiation Therapy and Radiation Oncology Dresden, Germany
  • Universitätsklinikum Freiburg, Department of Radiation Therapy and Radiation Oncology Freiburg im Breisgau, Germany
  • Praxis für Strahlentherapie Hamburg-Harburg Hamburg, Germany
  • Universitätsklinikum des Saarlandes, Department of Radiotherapy and Radiation Oncology Homburg, Germany
View Trial Details
Completed

A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid Tumors

NCT02955251

Conditions
Adnexal Diseases, Advanced Solid Tumors Cancer, Bronchial Neoplasms, +21 more
Locations
  • HonorHealth Research Institute - Pima /ID# 155461 Scottsdale, Arizona, United States
  • UC Davis Comprehensive Cancer Center - Main /ID# 154439 Sacramento, California, United States
  • University of Chicago /ID# 154440 Chicago, Illinois, United States
  • Fox Chase Cancer Center /ID# 170665 Philadelphia, Pennsylvania, United States
View all 15 locations
View Trial Details
Completed

A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC)

NCT02411591

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Charleroi, Belgium
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Leuven, Belgium
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Roeselare, Belgium
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Brest, France
View all 15 locations
View Trial Details
Completed

A Study of ASN007 in Patients With Advanced Solid Tumors

NCT03415126

Conditions
Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +51 more
Locations
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
View Trial Details
Completed

Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer

NCT00530621

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fayetteville, Arkansas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lancaster, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States
View all 25 locations
View Trial Details

Related conditions